Filing Details

Accession Number:
0001627223-22-000039
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-09 17:42:13
Reporting Period:
2022-05-05
Accepted Time:
2022-05-09 17:42:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1627223 Chemours Co CC Chemicals & Allied Products (2800) 464845564
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1645179 C David Shelton C/O The Chemours Company
1007 Market Street
Wilmington DE 19898
Svp, Gc & Corp. Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-05 83,044 $5.40 134,169 No 4 M Direct
Common Stock Disposition 2022-05-05 83,044 $39.99 51,125 No 4 S Direct
Common Stock Acquisiton 2022-05-05 67,736 $14.43 118,861 No 4 M Direct
Common Stock Disposition 2022-05-05 67,736 $39.99 51,125 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-05-05 83,044 $0.00 83,044 $5.40
Common Stock Stock Option (Right to Buy) Disposition 2022-05-05 67,736 $0.00 67,736 $14.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-03-01 No 4 M Direct
33,868 2030-03-02 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 91,992 Indirect By GRAT
Footnotes
  1. Includes directly owned shares, restricted stock units, and dividend equivalent units.
  2. Shares were sold in multiple transactions at prices ranging from $39.68 to $40.47.
  3. Option award was granted on March 1, 2016 with vesting in three equal annual installments beginning March 1, 2017.
  4. Option award was granted on March 2, 2020 with vesting in three equal annual installments beginning March 2, 2021.